Advances in remyelination and myelin repair are opening new possibilities in the future of MS treatment.
At Patient Community Day 2026, leading experts will explore the latest breakthroughs in this area – helping to explain what these developments could mean for people living with MS, now and in the years ahead.
📅 23 October 2026
🕒 15:00–18:00 EDT, plus a bonus hour of Q&A for online participants
🌍 Online + Toronto, Canada
🌐 Live translations available in 50+ languages
👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰: bit.ly/44elQGb
@ECTRIMS #PatientCommunityDay #MS #MSResearch #Remyelination #MyelinRepair
Iván retweeted
A recent study has unveiled two experimental compounds that show remyelination potential. See how this progress could redefine what we expect from future therapies: bit.ly/3JjPNOx
#MS #MultipleSclerosis #MSResearch #MSTreatment #EndMS #MSNews #MSNewsToday #Bionews
Iván retweeted
An experimental medication boosted motor function in mice and primate models of multiple sclerosis by repairing the myelin sheath. buff.ly/nd0G48b #MultipleSclerosis #MSTreatment #MSResearch #MSNews
Iván retweeted
PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in multiple sclerosis. bit.ly/4g1W2B2 #news
Iván retweeted
Researchers say their next step is to see if they can remove the need for transplants and edit cells directly in humans. bit.ly/4hc6mbf
#MS #MultipleSclerosis #MSResearch #MSNews #MSTreatment
Iván retweeted
Read this Q&A with NervGen’s President & CEO, Mike Kelly, and @Rob_TMM of the @medicine_maker to learn about NervGen’s lead drug, NVG-291, and the ongoing clinical trial for spinal cord injury.
Read the full article: themedicinemaker.com/discove…
#SCI #SpinalCordInjury
Iván retweeted
Treatment with PIPE-307, currently in Phase 2 testing for RRMS, was shown to promote remyelination in a mouse model of multiple sclerosis. bit.ly/3LYJWvM
#MSNews #MSAwareness #MSResearch #MSCommunity
Iván retweeted
Desarrollan un medicamento que podría revertir el daño provocado por la esclerosis múltiple - goo.gl/alerts/y8WyYH #GoogleAlerts
Desarrollan un medicamento que podría revertir el daño provocado por la esclerosis múltiple - goo.gl/alerts/y8WyYH #GoogleAlerts
Desarrollan una terapia que podría revertir el daño provocado por la esclerosis múltiple - goo.gl/alerts/WrVBxv #GoogleAlerts
Iván retweeted
Read about how researchers have identified characteristics of regulatory T-cells (Tregs) that “challenge common assumptions” and what this means for the future of targeted MS treatments: bit.ly/4deZ7wL
#MultipleSclerosis #MSTreatment #MSResearch #MSNews
Iván retweeted
A Phase 1 trial of ABA-101 for progressive multiple sclerosis is expected to launch by year's end after getting a green light from the FDA. bit.ly/4cY6bh6
#MultipleSclerosis #MSTreatment #MSResearch #MSNews
Iván retweeted
Read about a new study demonstrating how patients’ own cells may be used to deliver safe and effective treatments: bit.ly/3zAygwu
#MS #MultipleSclerosis #MSResearch #MSNews #MSTreatment
Iván retweeted
How might patients’ own cells be used to treat MS? New research points to the "healing abilities" of immune cells called neutrophils. bit.ly/45M9oxI
#MS #MultipleSclerosis #MSResearch #MSNews #MSTreatment
CAR-Ts achieve spectacular remissions against autoimmune diseases | Science - goo.gl/alerts/WjSBFb #GoogleAlerts
Iván retweeted
Certain immune cells are able to take on healing abilities allowing them to repair damaged nerve fibers, a possible strategy for treating MS. bit.ly/3zvwcWh #news
US FDA approved stem cell treatment study shows improvements in progressive MS patients - goo.gl/alerts/ybN4Hz #GoogleAlerts
Iván retweeted
Learn about significant findings that “offer new pathways for treatment” and a potential shift in therapeutic focus. bit.ly/3UZqyCX
#MS #MultipleSclerosis #MSResearch #MSNews #MSTreatment